Schubert & CO Horizon Therapeutics Public LTD CO Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$62.39 - $113.8 $2,121 - $3,869	34 Added 485.71%	41 $4,000
Q3 2022 Oct 21, 2022	SELL	$58.92 - $84.67 $1,237 - $1,778	-21 Reduced 75.0%	7 $0
Q2 2022 Aug 01, 2022	BUY	$79.4 - $116.36 $1,032 - $1,512	13 Added 86.67%	28 $2,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $259 - $329	3 Added 25.0%	15 $2,000
Q4 2021 Jan 28, 2022	BUY	$98.56 - $119.91 $1,182 - $1,438	12 New	12 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.